Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome- which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpointINTERNATIONAL JOURNAL OF CARDIOLOGYIF3.22025-02-011PRE
Soluble Urokinase Plasminogen Activator Receptor as a Predictor of All-Cause Death in Patients Undergoing Coronary Angiography at 10-Year Follow-UpJOURNAL OF CLINICAL MEDICINEIF2.92024-10-160OAAI
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter?JOURNAL OF CLINICAL MEDICINEIF2.92024-06-071OAAI
Predicting Short- and Long-Term Functional Outcomes Based on Serum S100B Protein Levels in Patients with Ischemic StrokeJOURNAL OF PERSONALIZED MEDICINEIF32024-01-102OAAI
Significance of S100B Protein as a Rapid Diagnostic Tool in Emergency Departments for Traumatic Brain Injury PatientsJOURNAL OF PERSONALIZED MEDICINEIF32023-12-181OAAI
48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting StentJOURNAL OF PERSONALIZED MEDICINEIF32023-11-031OAAI
Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year ResultsJOURNAL OF CLINICAL MEDICINEIF2.92023-08-155OAAI
The Comparison of Predicting Factors and Outcomes of MINOCA and STEMI Patients in the 5-Year Follow-UpJOURNAL OF PERSONALIZED MEDICINEIF32023-05-192OAAI
Clinical Characteristics and Predictors of In-Hospital Mortality of Patients Hospitalized with COVID-19 InfectionJOURNAL OF CLINICAL MEDICINEIF2.92022-12-244OAAI
6-year results of BiOSS stents in coronary bifurcation treatmentEUROPEAN JOURNAL OF CLINICAL INVESTIGATIONIF3.62021-03-293PRE
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-UpJOURNAL OF PERSONALIZED MEDICINEIF32021-03-065OAAI
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trialsEUROINTERVENTIONIF9.52020-03-016PRE
Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C RegistryARCHIVES OF MEDICAL SCIENCEIF3.32020-02-103OAAI
Platelet distribution width as the prognostic marker in coronary bifurcation treatmentEUROPEAN JOURNAL OF CLINICAL INVESTIGATIONIF3.62017-06-2718PREAI
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trialEUROINTERVENTIONIF9.52016-12-0131OA
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registryEUROINTERVENTIONIF9.52016-11-0117OA
Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I TrialCANADIAN JOURNAL OF CARDIOLOGYIF5.32015-05-0127PREAI
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers populationEUROINTERVENTIONIF9.52012-07-0118PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向